Vat-Photopolymerised Drug-Delivery and Pharmaceutical Devices: Resin Identity, Dose Incorporation, Release, Residuals and Qualification

Vat photopolymerisation can shape drug-loaded devices and use geometry to modify release, but printability is not pharmaceutical qualification. ER-193 separates resin identity, dose incorporation, delivered cure, residual chemistry, geometry, degradation, release and biological evidence. It uses two directly read primary abstracts as bounded anchors and does not convert research feasibility into a safety, efficacy, dosing or regulatory claim.